CERo Therapeutics Holdings, Inc.

NASDAQ (USD): CERo Therapeutics Holdings, Inc. (CERO)

Last Price

2.58

Today's Change

0.00 (0.00%)

Day's Change

0.00 - 0.00

Trading Volume

0

Overview

Market Cap

6 Million

Shares Outstanding

2 Million

Avg Volume

971,659

Avg Price (50 Days)

11.64

Avg Price (200 Days)

46.89

PE Ratio

-0.02

EPS

-118.56

Earnings Announcement

18-Feb-2025

Previous Close

2.80

Open

2.77

Day's Range

2.51 - 2.77

Year Range

2.51 - 1280.0

Trading Volume

324,540

Price Change Highlight

1 Day Change

-7.86%

5 Day Change

-23.44%

1 Month Change

-49.41%

3 Month Change

2695.23%

6 Month Change

1223.08%

Ytd Change

-57.70%

1 Year Change

-76.86%

3 Year Change

-73.99%

5 Year Change

-74.02%

10 Year Change

-74.02%

Max Change

-74.02%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment